Literature DB >> 25270736

Testing for risk and protective trends in genetic analyses of HIV acquisition.

Janice M Mccarthy1, Patrick R Shea2, David B Goldstein2, Andrew S Allen3.   

Abstract

Host genetics studies of HIV-1 acquisition are critically important for the identification of new targets for drug and vaccine development. Analyses of such studies typically focus on pairwise comparisons of three different groups: HIV-1 positive individuals, HIV-1 high-risk seronegative individuals, and population controls. Because there is a clear expectation of how gene frequencies of risk or protective alleles would be ordered in the three groups, we are able to construct a statistical framework that offers a consistent increase in power over a wide-range of the magnitude of risk/protective effects. In this paper, we develop tests that constrain the alternative hypothesis to appropriately reflect risk or protective trends jointly across the three groups and show that they lead to a substantial increase in power over the naive pairwise approach. We develop both likelihood-ratio and score statistics that test for genetic effects across the three groups while constraining the alternative hypothesis to reflect biologically motivated trends of risk or protection. The asymptotic distribution of both statistics (likelihood ratio and score) is derived. We investigate the performance of our approach via extensive simulation studies using a biologically motivated model of HIV-1 acquisition, and find that our proposed approach leads to an increase in power of roughly 10-28%. We illustrate our approach with an analysis of the effect of the CCR5Δ32 mutation on HIV acquisition.
© The Author 2014. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CCR5; Constrained alternative; HIV-1, Score statistic; High-risk seronegative

Mesh:

Substances:

Year:  2014        PMID: 25270736      PMCID: PMC4441099          DOI: 10.1093/biostatistics/kxu044

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  20 in total

1.  Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  R S Sperling; D E Shapiro; R W Coombs; J A Todd; S A Herman; G D McSherry; M J O'Sullivan; R B Van Dyke; E Jimenez; C Rouzioux; P M Flynn; J L Sullivan
Journal:  N Engl J Med       Date:  1996-11-28       Impact factor: 91.245

2.  Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population.

Authors:  Slavé Petrovski; Jacques Fellay; Kevin V Shianna; Nicole Carpenetti; Johnstone Kumwenda; Gift Kamanga; Deborah D Kamwendo; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Myron S Cohen; David B Goldstein
Journal:  AIDS       Date:  2011-02-20       Impact factor: 4.177

3.  Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.

Authors:  M Samson; F Libert; B J Doranz; J Rucker; C Liesnard; C M Farber; S Saragosti; C Lapoumeroulie; J Cognaux; C Forceille; G Muyldermans; C Verhofstede; G Burtonboy; M Georges; T Imai; S Rana; Y Yi; R J Smyth; R G Collman; R W Doms; G Vassart; M Parmentier
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

4.  Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya.

Authors:  K R Fowke; N J Nagelkerke; J Kimani; J N Simonsen; A O Anzala; J J Bwayo; K S MacDonald; E N Ngugi; F A Plummer
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

Review 5.  Transfusion medicine: looking to the future.

Authors:  Lawrence T Goodnough; Aryeh Shander; Mark E Brecher
Journal:  Lancet       Date:  2003-01-11       Impact factor: 79.321

6.  A whole genome association study of mother-to-child transmission of HIV in Malawi.

Authors:  Bonnie R Joubert; Ethan M Lange; Nora Franceschini; Victor Mwapasa; Kari E North; Steven R Meshnick
Journal:  Genome Med       Date:  2010-03-01       Impact factor: 11.117

7.  A genetic polymorphism of FREM1 is associated with resistance against HIV infection in the Pumwani sex worker cohort.

Authors:  Ma Luo; James Sainsbury; Jeffrey Tuff; Philip A Lacap; Xin-Yong Yuan; Taha Hirbod; Joshua Kimani; Charles Wachihi; Sue Ramdahin; Thomas Bielawny; Joanne Embree; Kristina Broliden; T Blake Ball; Francis A Plummer
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

8.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

9.  Common genetic variation and the control of HIV-1 in humans.

Authors:  Jacques Fellay; Dongliang Ge; Kevin V Shianna; Sara Colombo; Bruno Ledergerber; Elizabeth T Cirulli; Thomas J Urban; Kunlin Zhang; Curtis E Gumbs; Jason P Smith; Antonella Castagna; Alessandro Cozzi-Lepri; Andrea De Luca; Philippa Easterbrook; Huldrych F Günthard; Simon Mallal; Cristina Mussini; Judith Dalmau; Javier Martinez-Picado; José M Miro; Niels Obel; Steven M Wolinsky; Jeremy J Martinson; Roger Detels; Joseph B Margolick; Lisa P Jacobson; Patrick Descombes; Stylianos E Antonarakis; Jacques S Beckmann; Stephen J O'Brien; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Mary Carrington; Sheng Feng; Amalio Telenti; David B Goldstein
Journal:  PLoS Genet       Date:  2009-12-24       Impact factor: 5.917

10.  Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls.

Authors:  Paul J McLaren; Cédric Coulonges; Stephan Ripke; Leonard van den Berg; Susan Buchbinder; Mary Carrington; Andrea Cossarizza; Judith Dalmau; Steven G Deeks; Olivier Delaneau; Andrea De Luca; James J Goedert; David Haas; Joshua T Herbeck; Sekar Kathiresan; Gregory D Kirk; Olivier Lambotte; Ma Luo; Simon Mallal; Daniëlle van Manen; Javier Martinez-Picado; Laurence Meyer; José M Miro; James I Mullins; Niels Obel; Stephen J O'Brien; Florencia Pereyra; Francis A Plummer; Guido Poli; Ying Qi; Pierre Rucart; Manj S Sandhu; Patrick R Shea; Hanneke Schuitemaker; Ioannis Theodorou; Fredrik Vannberg; Jan Veldink; Bruce D Walker; Amy Weintrob; Cheryl A Winkler; Steven Wolinsky; Amalio Telenti; David B Goldstein; Paul I W de Bakker; Jean-François Zagury; Jacques Fellay
Journal:  PLoS Pathog       Date:  2013-07-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.